February 11 and 12, Norway's largest and most important conference for health and life sciences will take place: Norway Life Science 2025.
Norway Life Science 2025 brings together the country's leading players in health, life sciences, and artificial intelligence to find solutions that ensure Norway reaps greater benefits from its significant investments in health research.
"In a situation where Europe struggles to keep pace with the USA and China in science-based industries driven by enabling technologies, it is more important than ever to focus on outstanding research and cross-sector collaboration to implement disruptive ideas. At Norway Life Science, we will gather politicians, researchers, businesses, public actors, and investors to showcase research and find inspiration on how we can more rapidly streamline healthcare services and foster health industries from new ideas," says Svein Stølen, Rector at the University of Oslo.
Main Themes are Health Data and Artificial Intelligence
The main themes are health data and artificial intelligence, continuing the topic from 2024. Could artificial intelligence, coupled with health data, be the answer to tomorrow's challenges in healthcare, leading to new services and treatments, and make the Norwegian health industry internationally competitive and attractive for significant investments? We will summarize the status, what has happened the past year, and discuss the way forward.
Collaboration Between Researchers, Businesses, Public Actors, and Investors
The conference is an Oslo Science City Arena event in collaboration with leading partners. The University of Oslo organizes the event together with Oslo Science City, Oslo University Hospital, NMBU – Norwegian University of Life Sciences, SINTEF, Association of the Pharmaceutical Industry in Norway, Oslo Cancer Cluster, The Life Science Cluster, and Norway Health Tech. Industrial partners include AstraZeneca, GSK, Novartis, Novo Nordisk, Roche, Thermo Fisher, and Bayer.
– Norway has the best conditions for succeeding in the further development of an internationally competitive healthcare industry. Strong research environments, excellent health data, and outstanding digital competence give us a solid foundation. We are measured by our results and not our ambitions, and that is why Oslo Science City looks forward to meeting leading representatives from academia, healthcare, industry, startups, and authorities at Norway Life Science 2025, all of whom will help ensure that ambitions are converted into committed, concrete measures and activities, says Christine Wergeland Sørbye, CEO of Oslo Science City.
A Few Highlights from the Programme
At the conference, you will hear from the leading research environments in the country, key leaders in Norway's healthcare sector, globally leading pharmaceutical companies, startups, investors, and decision-makers. The full programme will be avaliable in December.
Some of the highlights include:
Minister of Digitalisation and Public Governance Karianne Tung will present the government's ambitions for further investment in health data.
We have three international keynote speakers: Timothy M. Miller, Vice President of Enterprise Science & Innovation at Thermo Fisher Scientific, Erwin Böttinger, Director at the Wyss Centre, and Jan Westenkær Thomsen from Niels Bohr Institute. They will discuss how artificial intelligence coupled with health data can address the major health challenges we face.
Erna Solberg, leader of the Conservative Party of Norway – Høyre, along with leaders from the Norwegian Institute of Public Health, the Directorate of Health, Oslo University Hospital, the pharmaceutical industry, and others will discuss what a targeted investment in health data means for developing a competitive Norwegian health industry and how research and innovation can be tools for developing a world-leading healthcare system.
On day two, we will focus on how we will deliver the healthcare services of tomorrow and how we can enhance Norwegian competitiveness, based on the report on European competitiveness by former European Central Bank President Mario Draghi. There will be a career event called Young Talents 2024 and a pitch competition for startups and innovation projects.
The full program and registration will be available in December.